Outpost Medicine

Biopharma, Biotechnology, Medical, Pharmaceutical
Founded in 2016-01-01
Indianapolis, Indiana, United States
For Profit

About Outpost Medicine

At Outpost, they are committed to developing novel therapeutics for the treatment of gastrointestinal and urologic disorders. The company's lead clinical-stage product candidate is in development for the treatment of overactive bladder (OAB) and irritable bowel syndrome (IBS).

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 7 active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 61000000 USD
  • Last Funding: 20000000 USD (Series A)
  • Funding Status: Early Stage Venture

Technology Stack

Outpost Medicine actively uses 7 products in their tech stack.

Market Presence

Industries: Biopharma, Biotechnology, Medical, Pharmaceutical

Headquarters: Indianapolis, Indiana, United States